Home The Company The People The Technology The Biomarker Market The Location
 

The Biomarker Market

Augurex’s lead biomarker is in the area of arthritis where there is a significant unmet need for a blood test that provides evidence of structural damage in the joint. Early detection of joint damage in arthritis is important so that physicians can intervene with suitable therapies that may change the course of the disease.

 
 
Home |  The Company |  The People |  The Technology |  The Biomarker Market |  The Location

© 2007 Augurex.com - All Rights Reserved.

Site By: Irtus Software Inc.